Neurogene
NGNE
Insider trades and stock quote 2024-2026
All insider trades at Neurogene
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/7/2026
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$36.1 |
$151,763 |
|
7/6/2026
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$36.0 |
$21,613 |
|
7/2/2026
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$34.9 |
$141,416 |
|
7/1/2026
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$34.1 |
$25,170 |
|
5/6/2026
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$31.2 |
$300,043 |
|
3/26/2026
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$21.6 |
$55,316 |
|
3/26/2026
|
Sell |
Mcminn, Rachel |
Chief Executive Officer |
$22.1 |
$73,995 |
|
3/26/2026
|
Sell |
Jordan, Julie |
Chief Medical Officer |
$21.9 |
$18,128 |
|
3/13/2026
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$21.2 |
$84,176 |
|
3/13/2026
|
Sell |
Cobb, Stuart |
Chief Scientific Officer |
$21.3 |
$141,446 |
|
2/27/2026
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$25.1 |
$120,526 |
|
5/14/2025
|
Sell |
Cobb, Stuart |
Chief Scientific Officer |
$15.2 |
$103,003 |
|
3/13/2025
|
Sell |
Cvijic, Christine Mikail |
President and CFO |
$16.9 |
$76,247 |
|
11/26/2024
|
Buy |
Samsara Biocapital Gp, LLC |
Ten Percent Owner |
$26.3 |
$1,259,623 |
|
11/22/2024
|
Buy |
Mcminn, Rachel |
Chief Executive Officer |
$20.4 |
$969,000 |
|
11/22/2024
|
Buy |
Cvijic, Christine Mikail |
President and CFO |
$20.5 |
$491,400 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address